Amphotericin B
Spécifications
1397-89-3Numéro CAS
215-742-2Numéro CE
(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,Nom IUPAC
C47H73NO17Formule chimique
924.1 g/molMasse molaire
amphotericin b; 1397-89-3; Amphotericine B; Amfotericina B; Halizon; Ampho-Moronal; Amphotericinum B; Fungizone; Amphocin; Amphotec; Fungilin; Amphozone; AmphotericinB; AMPH-B; Amphotocerin; Ambil; Amphotericin B liposome; Mysteclin-F; 7XU7A7DROE; DTXSID9022601; Amphotericin b, liposome; NS 718; NSC 527017; ABELCET, LIPOSOMAL AMPHOTERICIN B; Fungisone; CHEBI:2682; NSC-527017; 14,39-Dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,2 7,29,31-heptaene-36-carboxylic acid, 33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-(1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E, 25E-27E,29E,31E,33R*,35S*,36R*,37S*))-; amophotericin B; Amphotercin B; Amphotreicin B; Ampotericin B; Amphotericitin B; Amphomoronal; Amphotericinum; Fungilin In Orabase; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; DTXCID802601; NSC527017; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-((2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; RefChem:5552; A01AB04; A07AA07; G01AA03; J02AA01; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-((2R,3S,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-methyloxan-2-yl)oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate; (1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-((2R,3S,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-methyloxan-2-yl)oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo(33.3.1)nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylate; 14,39-Dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid, 33-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-, (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-; 215-742-2; Amphotericin; Abelcet; Ambisome; Amphotericin-B; Amphotericin B (85%); C47H73NO17; MFCD00877763; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-(((2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; Amphotericin B (~80%); ABLC; Abelecet; Amphortericin B; Anfotericine B; IAB; UNII-7XU7A7DROE; Fungisome; Amfotericina B [INN-Spanish]; Amphotericine B [INN-French]; Amphotericinum B [INN-Latin]; CCRIS 5963; Amphotericin B from Streptomyces sp.; Amphotericin B?; HSDB 3008; Amphotericin B [USP:INN:JAN]; Fungizone (TN); Amphotericin B RS; NCGC00090808-01; Amphotec (TN); (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; (1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20R,21S,25R,27R,30R,31R,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid; Amphotericin B; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-amino-3,6-dideoxy-ss-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; AmBisome (TN); Amp B; Amphotericin B CRS; EINECS 215-742-2; BRN 0078342; AI3-26528; Prestwick3_000410; Amphotericin B solubilized; Amphotericin B (Standard); AMPHOTERICIN B [MI]; SCHEMBL17973; AMPHOTERICIN B [INN]; AMPHOTERICIN B [JAN]; BSPBio_000340; 5-18-10-00525 (Beilstein Handbook Reference); AMPHOTERICIN B [HSDB]; BIDD:GT0351; AMPHOTERICIN B [VANDF]; BPBio1_000374; CHEMBL267345; NKTR-024; AMPHOTERICIN B [MART.]; AMPHOTERICIN B [USP-RS]; AMPHOTERICIN B [WHO-DD]; AMPHOTERICIN B [WHO-IP]; HY-B0221R; Amphotericin B (Injectable/Oral); HMS2096A22; HMS3713A22; Amphotericin B (JP18/USP/INN); Amphotericin B - Bio-X trade mark; HY-B0221; Amphotericin b, liposome [WHO-DD]; Amphotericin B, Streptomyces nodosus; AMPHOTERICIN B [ORANGE BOOK]; LMPK06000002; MSK158236; s1636; AMPHOTERICIN B [EP MONOGRAPH]; AKOS024464746; AMPHOTERICIN B [USP MONOGRAPH]; AA15700; AMPHOTERICIN B LIPOSOME [VANDF]; CCG-220410; DB00681; AMPHOTERICINUM B [WHO-IP LATIN]; NCGC00090808-08; NCGC00090808-14; (1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E,25E,27E,29E,31E,33R*,35S*,36R*,37S*))-33-((3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo(33.3.1)nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; AA161113; Amphotericin B for peak identification CRS; A2114; AB00513832; Amphotericin B for microbiological assay CRS; 1202017-46-6; LNS-AmB;Amphocin;fungilin;ABELCET;AMBISOME; C06573; D00203; AB00513832_02; Second International Standard for Amphotericin B; Q412223; 1397-89-3, C47H73NO17; Amphotericin B from Streptomyces sp., ~80% (HPLC), powder; Amphotericin B from Streptomyces sp., BioReagent, suitable for cell culture, ~80% (HPLC); Amphotericin B solubilized, powder, gamma-irradiated, BioXtra, suitable for cell culture; (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19Z,21Z,23Z,25Z,27Z,29Z,31Z,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; 4UH; Amphotericin B from Streptomyces sp., Vetec(TM) reagent grade, BioReagent, suitable for cell culture, ~80%Synonymes
Produits contenant Amphotericin B
암포좀주사(주사용리포좀화한암포테리신B)람포좀주사(주사용리포좀화한암포테리신B)(수출용)암비솜주사(주사용리포좀화한암포테리신B)훈기존주사50밀리그램(주사용암포테리신비)AMFOTERICINA B LIPOSOMAL TILLOMED 50 MG POLVO PARA CONCENTRADO PARA DISPERSION PARA PERFUSIONAMFOTERICINA B LIPOSOMAL HIKMA 50 MG POLVO PARA CONCENTRADO PARA DISPERSION PARA PERFUSIONAMBISOME LIPOSOMAL 50 MG POLVO PARA DISPERSION PARA PERFUSIONABELCET COMPLEJO LIPIDICO 5 mg/ml CONCENTRADO PARA DISPERSION PARA PERFUSIONFUNGIZONE NOURRISSONS ET ENFANTS 10 %, suspension buvableFUNGIZONE 50 mg, poudre pour solution injectableFUNGIZONE 10 %, suspension buvableAmphot 50mg
Page 1 sur 4
Entreprises vendant Amphotericin B
동국
동국제약(주)Republic of KoreaNC
North China Pharmaceutical Co., Ltd.ChinaAD
ACS DOBFAR SPAItalyPage 1 sur 4